Type 1 diabetes in Brazil: a narrative overview of the Brazilian Type 1 Diabetes Study Group.

ABSTRACT:

Background

To evaluate the real-world care of Brazilian individuals with type 1 diabetes (T1D).

Methods

The Brazilian Type 1 Diabetes Study Group (BrazDiab1SG), was conducted in two waves, in all Brazilian geographical regions. The first enrolled 3,591 individuals with data obtained from medical records. The second evaluated 1,760 individuals with laboratory and genetic data performed at State University of Rio de Janeiro.

Results

In the first and second waves, the average HbA1c was 9.3% and 9.0%, HbA1c above 10%, 32.2% and 26.3%, and individuals with HbA1c < 7.0%, 13.2% and 13.5%, respectively. Intermediate/long plus short acting insulins was the commonest used treatment modality. Less than 30% of the individuals achieved good glycemic control. Individuals in pumps a

SUBMITTER: Gomes MB 

PROVIDER: S-EPMC12102832 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature